BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
103.15
+0.45 (0.44%)
At close: Nov 28, 2025, 4:00 PM EST
102.90
-0.25 (-0.24%)
After-hours: Nov 28, 2025, 4:15 PM EST
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of $24.8 billion as of November 28, 2025. Its market cap has decreased by -4.85% in one year.
Market Cap
24.80B
Enterprise Value
8.05B
1-Year Change
-4.85%
Ranking
Category
Stock Price
$103.15
Market Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from $2.99B to $24.80B, an increase of 728.15%. That is a compound annual growth rate of 41.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 24.69B | -9.60% |
| Dec 31, 2024 | 27.32B | 8.89% |
| Dec 29, 2023 | 25.09B | -31.28% |
| Dec 30, 2022 | 36.51B | -41.37% |
| Dec 31, 2021 | 62.26B | 217.21% |
| Dec 31, 2020 | 19.63B | 156.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 993.82B |
| Johnson & Johnson | 497.93B |
| AbbVie | 409.68B |
| UnitedHealth Group | 295.56B |
| AstraZeneca | 288.24B |
| Merck & Co. | 262.25B |
| Novartis AG | 248.38B |
| Thermo Fisher Scientific | 224.59B |